Bachem Holding AG
BANB
Kedudukan dalam Saham
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Harga Saham
$100.60
Modal Pasaran
$7.54B
Perubahan (1 hari)
-1.49%
Perubahan (1 tahun)
49.53%
Negara
CH
Perdagangan Bachem Holding AG (BANB)
Kategori
Healthcare
Nisbah P/B bagi Bachem Holding AG (BANB)
Nisbah P/B pada October 2026 TTM: 4.31
Menurut laporan kewangan dan harga saham terkini Bachem Holding AG, nisbah P/B semasa (TTM) ialah 4.31. Pada akhir 2024, nisbah P/B syarikat ialah 3.12.
Sejarah nisbah P/B untuk Bachem Holding AG dari 2002 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 4.31 | 40.03% |
| 2025 | 3.08 | -1.34% |
| 2024 | 3.12 | -15.11% |
| 2023 | 3.68 | -26.96% |
| 2022 | 5.03 | -44.38% |
| 2021 | 9.05 | -22.23% |
| 2020 | 11.64 | 143.30% |
| 2019 | 4.78 | 18.05% |
| 2018 | 4.05 | -27.47% |
| 2017 | 5.59 | 66.84% |
| 2016 | 3.35 | 68.44% |
| 2015 | 1.99 | 4.79% |
| 2014 | 1.90 | -2.54% |
| 2013 | 1.95 | 29.71% |
| 2012 | 1.50 | 14.42% |
| 2011 | 1.31 | -37.56% |
| 2010 | 2.10 | -11.45% |
| 2009 | 2.37 | -17.55% |
| 2008 | 2.88 | -18.65% |
| 2007 | 3.54 | 13.43% |
| 2006 | 3.12 | -76.81% |
| 2005 | 13.44 | 424.43% |
| 2004 | 2.56 | 2,367.37% |
| 2003 | 0.10 | 11,444.44% |
| 2002 | 0.00 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 6.251 | 44.93% |
US
|
|
| 13.2547 | 207.32% |
US
|
|
| 4.4521 | 3.23% |
AU
|
|
| 6.3632 | 47.54% |
NL
|
|
| - | - |
CH
|
